These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2901930)

  • 1. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.
    Dixon JS; Page MC
    Rheumatol Int; 1991; 11(1):13-8. PubMed ID: 1678204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions of H2-receptor antagonists.
    Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
    Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
    Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
    Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short report: a comparative study of the interaction between antacid and H2-receptor antagonists.
    Sullivan TJ; Reese JH; Jauregui L; Miller K; Levine L; Bachmann KA
    Aliment Pharmacol Ther; 1994 Feb; 8(1):123-6. PubMed ID: 7910488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of two histamine H2-receptor antagonists, cimetidine and ranitidine, on the plasma levels and clinical effect of nifedipine and metoprolol.
    Kirch W; Rämsch K; Janisch HD; Ohnhaus EE
    Arch Toxicol Suppl; 1984; 7():256-9. PubMed ID: 6151387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine.
    Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E
    Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of the kinetics of the antisecretory effect and kinetics of blood concentration in man. Comparing cimetidine and ranitidine].
    Raoul JL; Trouvin JH; Farinotti R; Lewin MJ; Bonfils S
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):585-90. PubMed ID: 2753306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an antacid and food on the absorption of cimetidine and ranitidine.
    Desmond PV; Harman PJ; Gannoulis N; Kamm M; Mashford ML
    J Pharm Pharmacol; 1990 May; 42(5):352-4. PubMed ID: 1976784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased oral warfarin clearance after ranitidine and cimetidine.
    Desmond PV; Mashford ML; Harman PJ; Morphett BJ; Breen KJ; Wang YM
    Clin Pharmacol Ther; 1984 Mar; 35(3):338-41. PubMed ID: 6321081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of histamine-2 receptor antagonists on tocainide pharmacokinetics.
    North DS; Mattern AL; Kapil RP; Lalonde RL
    J Clin Pharmacol; 1988 Jul; 28(7):640-3. PubMed ID: 2905709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions of H2 antagonists and non-depolarizing muscle relaxants].
    Tryba M; Wruck G
    Anaesthesist; 1989 May; 38(5):251-4. PubMed ID: 2567580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of H2 receptor antagonists on the disposition of flurbiprofen enantiomers.
    Small RE; Cox SR; Adams WJ
    J Clin Pharmacol; 1990 Jul; 30(7):660-4. PubMed ID: 2391398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
    Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.